Delta-Fly Pharma (4598.T) Stock Price
Delta-Fly Pharma Price
Revenue at Delta-Fly Pharma has contracted by 19.8% per year over the past 5 years to 300.00 M JPY. Delta-Fly Pharma's net margin stands at -322.4%, down from 33.8% several years earlier.
Delta-Fly Pharma stock price
Delta-Fly Pharma business model & stock analysis
Frequently asked questions about Delta-Fly Pharma
Converted at the current exchange rate, the Delta-Fly Pharma share trades at 0.54 EUR (96.00 JPY).
The revenue cannot currently be calculated for Delta-Fly Pharma.
The profit of Delta-Fly Pharma is -1.63 B JPY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Delta-Fly Pharma is currently -0.83. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Delta-Fly Pharma stock.
The P/S cannot be calculated for Delta-Fly Pharma currently.
The Eulerpool Quality Score for Delta-Fly Pharma is 1/10.
The ISIN of Delta-Fly Pharma is JP3549370009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Delta-Fly Pharma is 4598.T. The ticker symbol is used to trade Delta-Fly Pharma shares on the stock exchange.
Delta-Fly Pharma stock
Delta-Fly Pharma Peer Group
Delta-Fly Pharma FIGI
All fundamentals and in-depth analysis of Delta-Fly Pharma
Our stock analysis for Delta-Fly Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Delta-Fly Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.